Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
Intel
INTC
|
+$972M |
| 2 |
Cisco
CSCO
|
+$610M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$572M |
| 4 |
International Flavors & Fragrances
IFF
|
+$492M |
| 5 |
Mastercard
MA
|
+$400M |
Top Sells
| 1 |
Apple
AAPL
|
+$1.31B |
| 2 |
DuPont de Nemours
DD
|
+$563M |
| 3 |
Qualcomm
QCOM
|
+$372M |
| 4 |
Merck
MRK
|
+$332M |
| 5 |
Microsoft
MSFT
|
+$305M |
Sector Composition
| 1 | Technology | 23.31% |
| 2 | Consumer Discretionary | 12.99% |
| 3 | Financials | 12.81% |
| 4 | Healthcare | 12.55% |
| 5 | Communication Services | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
876
Genpact
G
$7.55B
| $38.4M | 0.01% |
896,379
-107,534
| -11% | -$4.6M |
|
877
Tetra Tech
TTEK
$9.51B
| $38.4M | 0.01% |
1,413,645
+30,155
| +2% | +$819K |
|
|
PDM
878
Piedmont Realty Trust, Inc.
PDM
$1.09B
| $38.2M | 0.01% |
2,199,110
-121,703
| -5% | -$2.11M |
|
879
Mercado Libre
MELI
$119B
| $38.1M | 0.01% |
25,849
+1,567
| +6% | +$2.31M |
|
880
FormFactor
FORM
$2.36B
| $38M | 0.01% |
841,651
-151,615
| -15% | -$6.84M |
|
881
Fate Therapeutics
FATE
$118M
| $37.8M | 0.01% |
459,025
-5,729
| -1% | -$472K |
|
882
F5
FFIV
$19.2B
| $37.8M | 0.01% |
181,410
-26,948
| -13% | -$5.62M |
|
883
Emergent Biosolutions
EBS
$439M
| $37.8M | 0.01% |
406,984
+41,594
| +11% | +$3.86M |
|
884
Bloom Energy
BE
$15.7B
| $37.8M | 0.01% |
1,397,048
-154,737
| -10% | -$4.19M |
|
885
UFP Industries
UFPI
$6B
| $37.7M | 0.01% |
496,913
+16,614
| +3% | +$1.26M |
|
886
American Financial Group
AFG
$11.7B
| $37.7M | 0.01% |
330,277
-17,521
| -5% | -$2M |
|
887
Lennox International
LII
$19.9B
| $37.4M | 0.01% |
120,147
-6,425
| -5% | -$2M |
|
|
SAFM
888
DELISTED
Sanderson Farms Inc
SAFM
| $37.4M | 0.01% |
239,910
+156,805
| +189% | +$24.4M |
|
889
Revvity
RVTY
$9.95B
| $37.4M | 0.01% |
291,218
-88,311
| -23% | -$11.3M |
|
|
ATH
890
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $37.3M | 0.01% |
739,263
-15,998
| -2% | -$806K |
|
891
Pacific Biosciences
PACB
$378M
| $37.3M | 0.01% |
1,118,420
+280,568
| +33% | +$9.35M |
|
892
Halozyme
HALO
$9.07B
| $37.2M | 0.01% |
891,506
-124,205
| -12% | -$5.18M |
|
893
RLJ Lodging Trust
RLJ
$1.16B
| $37.1M | 0.01% |
2,397,373
+88,638
| +4% | +$1.37M |
|
894
Dine Brands
DIN
$372M
| $37M | 0.01% |
410,462
+150,324
| +58% | +$13.5M |
|
|
XLRN
895
DELISTED
Acceleron Pharma Inc.
XLRN
| $36.9M | 0.01% |
272,181
-8,162
| -3% | -$1.11M |
|
896
Insight Enterprises
NSIT
$4.07B
| $36.9M | 0.01% |
386,580
-4,003
| -1% | -$382K |
|
897
Acadia Pharmaceuticals
ACAD
$4.08B
| $36.9M | 0.01% |
1,428,987
-27,570
| -2% | -$711K |
|
898
Outfront Media
OUT
$3.13B
| $36.9M | 0.01% |
1,715,591
+1,199,639
| +233% | +$25.8M |
|
899
First Interstate BancSystem
FIBK
$3.41B
| $36.8M | 0.01% |
800,323
+43,451
| +6% | +$2M |
|
|
JBGS
900
JBG SMITH
JBGS
$1.44B
| $36.8M | 0.01% |
1,158,992
+768,068
| +196% | +$24.4M |
|